KDx Diagnostics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
KDx Diagnostics General Information
Description
Developer of diagnostic test devices designed to improve the early detection and management of cancer. The company offers an immunohistochemical proprietary test that detects bladder cancer from urine samples based on a novel biomarker, keratin seventeen, and is compatible with most autostainer platforms that are available in most reference laboratories, enabling clinicians to detect recurrent bladder cancers.
Contact Information
Website
www.kdxdiagnostics.comCorporate Office
- 14527 South Bascom Avenue
- Los Gatos, CA 95032
- United States
Corporate Office
- 14527 South Bascom Avenue
- Los Gatos, CA 95032
- United States
KDx Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 30-May-2019 | Completed | Generating Revenue |
KDx Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-D | ||||||||
| Seed-C | ||||||||
| Seed-B | 613,941 | $0.000100 | $0.75 | $0.75 | 1x | $0.75 | 8.11% |
KDx Diagnostics Patents
KDx Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3070222-A1 | Keratin 17 as a biomarker for bladder cancer | Pending | 05-Aug-2016 | ||
| EP-3493819-A1 | Keratin 17 as a biomarker for bladder cancer | Active | 05-Aug-2016 | ||
| EP-3493819-A4 | Keratin 17 as a biomarker for bladder cancer | Active | 05-Aug-2016 | ||
| EP-3493819-B1 | Keratin 17 as a biomarker for bladder cancer | Active | 05-Aug-2016 | ||
| EP-4115891-A1 | Keratin 17 as a biomarker for bladder cancer | Pending | 05-Aug-2016 | C12Q1/6886 |
KDx Diagnostics Signals
KDx Diagnostics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Saudi Biotechnology Accelerator | Accelerator/Incubator |
KDx Diagnostics FAQs
-
When was KDx Diagnostics founded?
KDx Diagnostics was founded in 2017.
-
Where is KDx Diagnostics headquartered?
KDx Diagnostics is headquartered in Los Gatos, CA.
-
What is the size of KDx Diagnostics?
KDx Diagnostics has 10 total employees.
-
What industry is KDx Diagnostics in?
KDx Diagnostics’s primary industry is Diagnostic Equipment.
-
Is KDx Diagnostics a private or public company?
KDx Diagnostics is a Private company.
-
What is KDx Diagnostics’s current revenue?
The current revenue for KDx Diagnostics is .
-
How much funding has KDx Diagnostics raised over time?
KDx Diagnostics has raised $1.66M.
-
Who are KDx Diagnostics’s investors?
Saudi Biotechnology Accelerator has invested in KDx Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process